Introduction
Prostate cancer is the most prevalently detected malignancy and the second major risk of male mortality in Western countries. 1 Prostate cancer mortality occurs due to bone and lymph node metastases and reversion from androgen-dependent to androgen-independent prostatic growth. 2 The androgen-dependent stage of prostate cancer may be effectively treated with androgen deprivation therapy, resulting in involution of the prostate gland, due Different parts of M. koenigii are used for the treatment of chronic fever, dysentery, dyspepsia, nausea, dropsy, mental impairment, diabetes, and diarrhea. [7] [8] [9] Different carbazole alkaloids with considerable biological activities and properties have been extracted from M. koenigii. 7 Apoptosis and cell cycle arrest are vital mechanisms associated with the suppression of cell proliferation using several chemotherapeutic agents. 7, 10, 11 In addition, constitutive stimulation of nuclear factor-kappa B (NF-κB) is common in different human cancers, including prostate cancer, leading to the upregulation of proteins encoding adhesion molecules, inflammatory cytokines, growth factors, and anti-apoptotic proteins. 12 Accordingly, the inhibition of the NF-κB signaling pathway is an important chemotherapeutic objective. 7, 13 Many different human cancer cell lines reflecting the characteristics of cancer tissues have been established for biological and genetic studies, chemoresistance, and drug therapeutic approaches.
14 A more recent approach in the treatment of cancer is the targeting of cancer stem cells (CSCs), which is accountable for the development of chemoresistance as reported in previous scientific evidences. 7, 15, 16 The concept of CSCs states that only some cells from the heterogeneous malignant cells within the tumor itself have the capability to induce cancer. 17 The population of these malignant cells is called CSCs due to their stem cell-like characteristics of self-renewal, differentiation, and tissue genesis. 18 The specific aim of the CSC concept is the advancement of CSC-targeting treatments that would substantially improve recent cancer therapies. 19, 20 The PC-3 cell is considered as a classical prostate cancer cell line. It is used as a model of androgen-independent prostate cancer. 21, 22 This cell line has high metastatic potential compared to other prostate cancer cell line models. 23, 24 Therefore, the current study is aimed at investigating the anticancer effect of koenimbin against PC-3 cells and PC-3-derived prostate CSCs (PCSCs) and its potential to induce the extrinsic and/or intrinsic apoptotic signaling pathways and inhibition of prostasphere formation of PC-3 CSCs.
Materials and methods Materials
In this study, koenimbin was extracted from the leaves of M. koenigii with a purity of 98.5%, which was obtained as a generous gift from Prof Aspollah Sukari, Faculty of Science, University Putra Malaysia (UPM). The chemical and physical features of koenimbin ( Figure 1 ) were consistent with those of previous studies. 7, 25 cell cultures RWPE-1 cells (normal human prostate cells) and human PC-3 cells from the American Type Culture Collection (ATCC, Manassas, VA, USA) were obtained as a gift from Dr Yeap Swee Keong at the Institute of Bioscience (IBS), UPM. The PC-3 cells were cultured in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS), streptomycin (100 Ig/mL) (Gibco BRL; Thermo Fisher Scientific, Waltham, MA, USA), and penicillin (100 IU/mL). The RWPE-1 cells were cultured in keratinocyte serum-free medium (K-SFM kit) supplemented with 0.2 ng/mL of epidermal growth factor and 25 µg/mL of bovine pituitary extract. The cells in the exponential growth phase with approximately 70%-80% confluency were cultured for experimental purpose in a humidified atmosphere using a 5% CO 2 incubator at 37°C. The cultured cells were screened for Mycoplasma species using GenProb detection kit (Gen-Probe, San Diego, CA, USA) according to the manufacturer's instructions.
cell viability assay of koenimbin-induced Pc-3 cells
Cell viability of the koenimbin-induced PC-3 cells was assessed using MTT assay. Approximately 1×10 5 PC-3 and RWPE-1 cells/mL were seeded in a 96-well plate and incubated for 24 h at 37°C with 5% CO 2 saturation. The next day, a serial dilution of koenimbin was applied to the 
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inhibition of human Pc-3 cancer stem cells PC-3 and RWPE-1 cells and incubated for 24, 48 , and 72 h, and then 20 µL of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT solution, 5 mg/mL) was added to the koenimbin-treated PC-3 and RWPE-1 cells in a dark place and covered with aluminum foil for 4 h. After that, the media was discarded and 100 µL volume of dimethyl sulfoxide (DMSO) was added into each well until the purple formazan crystals dissolved. The plate was read using a microplate reader at an absorbance of 570 nm. The experiment was performed in triplicate (n=3) to determine the antiproliferative effect of the IC 50 of koenimbin against the PC-3 and RWPE-1 cells.
isolation of Pcscs
Candidate PC-3 CSCs with the expression of CD44+/ CD133+ cell surface markers as tumor-initiating population 26 were derived from PC-3 cells using a catcher tube-based cell sorter with flow cytometer (FACSCalibur™; BD Biosciences, San Jose, CA, USA 
nonadherent prostasphere formation assay
PCSCs derived from PC-3 cells were seeded in six-well ultralow attachment plates (TPP; Thermo Fisher Scientific) with a density of 1,000 cells/mL of culture medium. 20 The cells have the capability to grow and form spheres in serum-free DMEM/ F12 media (Lonza, USA) supplemented with 0.2 ng/mL of epidermal growth factor and 25 µg/mL of bovine pituitary extract. In addition, B27 (Thermo Fisher Scientific), 20 ng/mL epidermal growth factors (Thermo Fisher Scientific), and 20 ng/mL basic fibroblast growth factors (Thermo Fisher Scientific) were added to the cell culture media. Fresh medium was added every 2 days to each well. The primary cultures of PC-3 CSCs were incubated with koenimbin at various concentrations of 0, 2, 4, 8, and 10 µg/mL for prostasphere formation. The treated primary PC-3 CSCs were then subcultured to secondary and tertiary passages for each group. After 5-7 days, the number and size of the prostaspheres were compared to the control cells and images were acquired with MetaMorph 7.6.0.0 using the Eclipse TE2000-S microscope (Nikon Corporation, Tokyo, Japan).
Aldefluor enzymatic assay
A prostate cell population with high aldehyde dehydrogenase (ALDH) activity was previously examined for the enrichment of breast stem/progenitor cells. 7 An Aldefluor™ enzymatic assay (StemCell Technologies, Herndon, VA, USA) was performed according to the manufacturer's instructions. Briefly, separated PC-3 CSCs derived from PC-3 cells were incubated for 40 min at 37°C in 5% CO 2 , and the results were then obtained using a flow cytometer.
acridine orange (aO)/propidium iodide (Pi) staining and ultramorphological assessment of apoptosis Human PC-3 cells were examined using AO and PI with standard procedure, 27 and the results were analyzed under fluorescence microscopy (Leica attached with Q-Floro Software; Leica Microsystems, Wetzlar, Germany). Briefly, approximately 1×10 5 PC-3 cells/mL were seeded in a small 25 mL culture flask and then treated with 6 µg/mL of koenimbin for 48 h. After that, the PC-3 cells were collected and spun down at 200 g for 5 min to remove the medium. Prior to staining with AO/PI, the PC-3 cells were washed twice with cool phosphate-buffered saline (PBS). Then, equal amounts of fresh AO/PI (10 µg/mL) were prepared and added to the cells on a glass slide using a cover slip. About 30 min prior to the fluorescence fading, the slides were observed using fluorescence microscopy.
Bioluminescence assay of caspase-3/7, caspase-8, and caspase-9 
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Kamalidehghan et al koenimbin for 24 h. The PC-3 cells were harvested and stained with a BD cycletest Plus DNA reagent kit (BD Biosciences) according to the manufacturer's protocols and subjected to cell cycle analysis using Guava easyCyte 8HT benchtop flow cytometer (Merck & Co., Inc., Whitehouse Station, NJ, USA).
nuclear morphology, membrane permeability, mitochondrial membrane potential (MMP), and cytochrome c release analysis
Approximately 1×10 5 PC-3 cells/mL were plated in a 96-well plate (Genetix USA Inc, San Jose, CA, USA) and incubated for 24 h at 37°C with 5% CO 2 . The PC-3 cells were then exposed to 6 µg/mL koenimbin for 48 h. A Cellomics Multiparameter Cytotoxicity 3 Kit (Cellomics, Pittsburgh, PA, USA) was employed for the identification of nuclear morphology, membrane permeability, MMP, and cytochrome c release. 28 MMP dye and the cell permeability dye were used to determine live cells and incubated for 1 h. After that, the nucleus was stained using Hoechst 33258 dye. The cells were then analyzed using Cellomics ArrayScan high-content screening (HCS) reader (Cellomics, Pittsburgh, PA, USA).
rna extraction and cDna synthesis of Bcl-2, Bax, and hsP70
RNA from the control cells and PC-3 cells induced with koenimbin concentrations of 4 and 6 µg/mL for 48 h was extracted using RNeasy Mini Kit (Qiagen NV, Venlo, the Netherlands) according to the manufacturer's instructions. After that, 1 µg of RNA was then subjected to cDNA synthesis using the QuantiTect Reverse Transcription Kit (Qiagen NV). Approximately 1 µg of cDNA was used for polymerase chain reaction (PCR) amplification using specific primers for the Bax, Bcl-2, and HSP70 genes. β-Actin mRNA was employed as the loading internal control.
The primers for Bax are sense, 5′-TTT GCT TCA GGG TTT CAT CC-3′, and antisense, 5′-GCC ACT CGG AAA AAG ACC TC-3′; the primers for Bcl-2 are sense, 5′-ATG AAC TCT TCC GGG ATG G-3′, and antisense, 5′-TGG ATC CAA GGC TCT AGG TG-3′; the primers for HSP70 are sense, 5′-CGC AGC TGA ACA AGC TAA ACA ATC-3′, and antisense, 5′-GAT TGT TTA GCT TGT TCA GCT GCG-3′; and the primers for β-actin are sense, 5′-CGG GAA ATC GTG CGT GAC-3′, and antisense, 5′-GCC TAG AAG CAT TTG CGG TG-3′. PCR amplification was carried out using a thermal cycle, and the reaction was initiated with preliminary denaturation at 95°C for 5 min, followed by 30 cycles of denaturation, annealing, and extension at 95°C for 30 s, 60°C for 40 s, and 72°C for 1 min, respectively. The reaction was completed after final extension at 72°C for 10 min. The amplification product sizes of Bax, Bcl-2, and β-actin were 213, 166, and 515 bp, respectively. The PCR products were exposed to 1.5% agarose gel electrophoresis, then stained, and visualized under ultraviolet (UV) light using Gel Doc XR System (Bio-Rad Laboratories Inc., Hercules, CA, USA).
Human apoptotic protein profiler array
PC-3 cells induced with 6 µg/mL of koenimbin for 48 h were compared to the control untreated PC-3 cells to determine the apoptotic-associated proteins using a proteome profiler array (human apoptosis antibody array kit; RayBiotech, Norcross, GA, USA), according to the manufacturer's instructions. Briefly, 250 µg of extracted protein from each sample was incubated with antibody array membrane and was then quantified using a Biospectrum AC ChemiHR 40 system (UVP, Upland, CA, USA). The membrane was analyzed using online ImageJ analysis software.
Western blot analysis
The koenimbin-induced PC-3 cells with different concentrations of 4, 8, and 16 µg/mL were cultured in a small 25 mL flask (TPP Brand, Trasadingen, Switzerland). Briefly, the PC-3 cells were collected, washed with PBS, centrifuged, and mixed with lysis buffer (50 mM Tris-HCL pH 8.0, 120 mM NaCl, 0.5% NP-40, 1 mM phenylmethanesulfonyl fluoride) to extract the proteins from the control and treated PC-3 cells. Approximately 40 µg of extracted proteins was separated using 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and then moved to the polyvinylidene difluoride (PVDF) membrane (Bio-Rad Laboratories Inc.), and PVDF membrane was blocked with 5% nonfat milk mixed with Tris-buffered Saline (TBS)-Tween buffer (0.12 M Tris-base, 1.5 M NaCl, 0.1% Tween 20) for 30 min at room temperature. The membranes were then incubated with the appropriate primary antibodies (Bax, Bcl-2, HSP70, and β-actin) overnight at 4°C. After that, the membranes were washed with TBS-Tween buffer, incubated with alkaline phosphatase-conjugated goat anti-mouse or goat anti-rabbit secondary antibodies for 30 min at room temperature, and then washed with TBST buffer. The primary antibodies such as β-actin (sc-130300), Bax (sc-20067), HSP70 (sc-69705), NF-κB/P65 (sc-398442), were purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA), while Bcl-2 (ab38629) was purchased from Abcam, Cambridge, UK. After washing three times with TBST, the PVDF membranes were incubated for 20 min at room temperature with 
statistical analysis
In this study, statistical analysis was calculated using Statistical Package for Social Sciences version 16.0 (SPSS Inc., Chicago, IL, USA) software. The experiments are reported as mean ± SD of three independent experiments. Normality and homogeneity of variance assumptions were tested. A P-value of 0.05 is statistically significant.
Results

MTT cell viability assay
The effect of koenimbin on PC-3 and RWPE-1 cells was evaluated using MTT method ( Figure 2 ; Table 1 isolation of cD44+/cD133+ surface markers of Pcscs
In this study, the CD44+/CD133+ surface markers of PCSCs were first isolated from PC-3 cells using cell sorting based on CD44+/CD133+ surface marker expression and were then cultured in prostasphere formation conditions. PCSCs derived from PC-3 cells were identified by the expression of CD44 and CD133 cell surface markers ( Figure 3A and B).
inhibitory effect of koenimbin on prostasphere formation
Prostasphere formation culture was carried out in serum-free media. The number of prostaspheres was calculated under a Nikon Eclipse TE2000-S microscope (Nikon, Japan), and images were then interpreted using MetaMorph 7.6.0.0. It has been demonstrated that prostate stem/progenitor cells enrich prostaspheres as nonadherent spherical clusters of cells. 34 Therefore, PC-3 CSCs were exposed to different concentrations of koenimbin to evaluate whether koenimbin has the capability to inhibit prostasphere formation in vitro. According to our results, koenimbin suppressed the nonadherent spherical clusters of PCSCs in vitro, in which these cells were not able to generate secondary spheres and differentiate along multiple lineages. As shown in Figure 4A and B, koenimbin significantly (P0.01) suppressed prostasphere formation with increasing concentrations of koenimbin ( Figure 4A and B).
inhibitory effect of koenimbin in an alDh-positive cell population
The PC-3 cell population with high ALDH activity ( Figure 5A and B) as determined using the Aldefluor assay demonstrated 
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Kamalidehghan et al enriched prostate stem/progenitor cells and increased self-renewal of PC-3 CSCs. As shown in Figure 5C , koenimbin with concentrations of 2, 4, 8 and 10 µg/mL significantly (P0.01) decreased the ALDH-positive population of PC-3 CSCs by approximately 20%, 33%, 53%, and 70%, respectively. This result demonstrates that koenimbin effectively reduced the PC-3 CSC population in vitro. In this study, koenimbin has the capability to suppress PC-3 CSCs at concentrations of 4, 8, and 10 µg/mL, hardly affecting the RWPE-1 cell population, revealing that koenimbin may preferentially have potential properties to target PC-3 CSCs.
Quantification of apoptotic cells using aO/Pi
Approximately 200 cell populations of PC-3 cells were randomly and differentially scored for viable, necrotic, early, and late apoptotic events using fluorescence microscopy. Our study indicated that koenimbin has the capability to trigger the morphological characteristics that are associated with apoptotic events. The viable untreated PC-3 cells were observed to have an intact green color. However, early apoptosis was observed with bright green color due to incorporation of AO within the fragmented DNA. In addition, blebbing and nuclear changes were noticed in koenimbininduced PC-3 cells at 48 h post treatment. Late apoptotic events were observed as orange color due to AO binding to denatured DNA (Figure 6 ).
Enzymatic caspase-3, caspase-7, caspase-8, and caspase-9 activation assays
The activation of caspase-3, caspase-7, caspase-8, and caspase-9 was examined through bioluminescence assay in koenimbin-induced PC-3 cells. In this experiment, koenimbin promoted the activation of caspase-3, caspase-7, and caspase-9 in koenimbin-induced PC-3 cells. However, the koenimbin-induced PC-3 cells demonstrated a lack of remarkable stimulation associated with caspase-8 in koenimbin-induced PC-3 cells (Figure 7 ). These results indicated that koenimbin has the capability to induce apoptosis in PC-3 cells through the intrinsic apoptotic signaling pathway.
cell cycle analysis
According to the cell cycle analysis, koenimbin-induced PC-3 cells demonstrated remarkable cell cycle alterations and distributions with the increase in cell arrest in the G 0 /G 1 phase. However, a reduction in cell cycle arrest was observed in the S and G 2 /M phases at a concentration of 6 µg/mL. Hence, the cell cycle analysis revealed a significant (P0.05) inhibitory effect of koenimbin in PC-3 cells (Figure 8A -E). 
Multiparametric hcs assays
To verify the induction of apoptosis by koenimbin, the induced cells were examined for cellular abnormalities accompanying apoptosis using HCS. The koenimbin-induced PC-3 cells indicated an increase in nuclear condensation using nuclear chromatin staining with Hoechst 33342. Membrane permeability of the koenimbin-induced PC-3 cells was increased in the cytoplasm of induced cells in comparison with the control cells. MMP was remarkably reduced in koenimbininduced PC-3 cells compared to untreated control cells. The cytochrome c involved in apoptotic signaling pathway was enhanced in the cytoplasm of koenimbin-induced PC-3 cells at a concentration of 6 µg/mL ( Figure 9 ). The results further demonstrated that koenimbin has the capability to inhibit proliferation of PC-3 cells through inducing the apoptotic signaling pathway.
reverse transcription Pcr (rT-Pcr) analysis of Bax and Bcl-2 mrna expressions
The expression of Bax and Bcl-2 mRNA ( Figure 10 ) was determined using RT-PCR. Gene expression of Bax was upregulated in untreated PC-3 cells and was remarkably (P0.05) increased in the koenimbin-induced PC-3 cells. In contrast, the expression of Bcl-2 and HSP70 was significantly (P0.05) downregulated in koenimbin-induced PC-3 cells compared to untreated cells.
human apoptotic protein array
Koenimbin-induced PC-3 cells were lysed, and the important apoptotic markers were screened using a protein array. The images represent changes in apoptotic markers between treated and untreated cells. All major markers responsible for the apoptosis signaling pathway, including Bax, Bcl-2, cytochrome c, and caspase-3/7 and caspase-9, were expressed in this in vitro model. In this study, a remarkable downregulation of HSP70, Bcl-2, and XIAP was observed, while protein expressions of Bax, cytochrome c, and SMAC were increased in this in vitro model. To confirm the protein array result, the expression of Bcl-2, Bax, and HSP70 in koenimbin-induced PC-3 cells was determined using Western blot analysis ( Figure 11 ).
Koenimbin inhibits TnF-α-induced nF-κB nuclear translocation
Previous reports indicated that triggering NF-κB nuclear translocation inhibits apoptotic signaling pathways and increases proliferation of cells. 7 As indicated in Figure 12A -C, koenimbin-induced PC-3 cells effectively decreased the NF-κB nuclear protein at concentrations of 8 and 16 µg/mL.
Western blot analysis
Western blot analysis on total extracted proteins from koenimbin-induced PC-3 cells confirmed the human protein array results. Bax protein expression, as a proapoptotic protein, was gradually upregulated, while HSP70 protein expression and Bcl-2 protein expression, as antiapoptotic proteins, were gradually downregulated with increasing concentrations of koenimbin following treatment for 24 h. β-Actin was employed as a loading control, which displayed identical intensity bands, proving equivalent protein concentration in all samples ( Figure 13 ).
Discussion
In this study, we attempted to manifest the mechanism of action of koenimbin on human androgen-independent PC-3 cell line. The inhibition effect of koenimbin on human breast cancer cells and derived breast CSCs was investigated in our previous study. 7 The koenimbin effect on human breast cancer cells was mediated through the induction of an apoptotic process via the mitochondrial pathway. 7 Cell viability assays on koenimbin-induced PC-3 cells exhibited strong apoptotic induction in PC-3 cells that have been further carried out with morphological study using fluorescent microscopy AO/PI staining assay. The outcome of this study was affirmed by multiparametric cell-based HCS analysis that revealed morphological feature characteristics of apoptotic cell death, including nuclear condensation, loss of membrane symmetry, release of mitochondrial cytochrome c, and decrease in MMP.
Previous studies indicated that the disruption of the MMP is an early important event in apoptosis, triggering release of cytochrome c and other associated apoptotic molecules from the mitochondria to the cytosol. The activation of apoptotic proteins results in the stimulation of different caspases and then leads to programmed cell death. Different studies demonstrated that the apoptotic processes can be triggered through the extrinsic pathway, where the ligand-receptor binding triggers caspase-8 and/or via the mitochondrial pathway, in which cytochrome c is moved from the mitochondria to stimulate caspase-9. 7, 29, 30 The caspase-9 stimulation results in the activation of the downstream caspase-3/7, which is accountable for the characteristics of apoptosis-associated morphological changes, including chromatin condensation, membrane blebbing, and cell shrinkage. 31, 32 The current study demonstrated that koenimbin-induced PC-3 cells increased the activity of caspase-3/7 and caspase-9, disrupted the MMP, and released mitochondrial cytochrome c into the cytosol. These results suggest that apoptosis is mediated through the intrinsic or mitochondrial signaling pathway. Previous studies showed the role of oxidative stress in the process of apoptosis and the associated mitochondrial alterations. 33, 34 Bcl-2 family proteins play a fundamental role in apoptosis, and up to 14 members of the Bcl-2 family have been identified. The first category of this family is pro-apoptotic proteins including Bax, Bak, and Bcl-Xs, and the second category is antiapoptotic proteins including Bcl-2, Bcl-XL, and Mcl-1. The Bcl-2 protein is located in the mitochondria, endoplasmic reticulum, and nuclear membranes, where most of the reactive oxygen species (ROS) are produced and where the free radicals realize their apoptotic influences. Bcl-2 protein plays as an antioxidant role to suppress the apoptotic process. 35 However, Bax proteins, which exist in the cytosol, stimulate apoptosis by associating themselves with 
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Kamalidehghan et al the membrane, leading to the loss of selective mitochondrial ion permeability. 7, 36 The Bcl-2/Bax protein ratio plays a remarkable role in the apoptotic process. 37 A study indicated that the Bcl-2 family proteins possess an important function in the regulation of mitochondrial-mediated apoptosis. It has also been stated that Bcl-2 restrains ROS-induced apoptosis, while the upregulation of pro-apoptotic Bax protein promotes ROS production. 38 Consistent with previous studies on koenimbin-induced MCF-7 breast cancer cells, 7 our results demonstrated that the induction of the apoptotic signaling pathway in koenimbin-induced PC-3 cells is modulated by the downregulation of Bcl-2 and HSP70 and upregulation of Bax protein expressions.
The apoptotic process is intimately associated with cell cycle arrest. 39, 40 It has been reported that cell cycle control is a substantial incident in the maintenance of precise cellular division. Numerous carcinogenic substances, including natural and synthetic compounds, were reported to promote chemoresistance and tumorigenesis through cell cycle dysregulation and inhibition of apoptosis in cancer cells. Many evidences have indicated that different chemotherapeutic compounds are able to stimulate the NF-κB signaling pathway, resulting in resistance to apoptosis. 43, 44 Other studies reported that the stimulation of the NF-κB signaling pathway induces inflammation leading to tumorigenesis. 45, 46 In clinical investigations on prostate cancer, the upregulation of the NF-κB/p65 protein was exhibited as an independent prognosis marker in prostate cancer patients. 31, 47 In prostatectomy samples from prostate cancer patients with recrudesce tumor, high intensity of NF-κB was observed in nuclear fraction. 31, 48 Therefore, efficient suppression of NF-κB signaling pathway is an essential signaling pathway for the prevention of prostate cancer. 49 In agreement with previous studies, 7, 50, 51 we observed a remarkable translocation of cytoplasmic NF-κB to the nuclei in koenimbin-induced PC-3 cells stimulated by TNF-α. Our results demonstrated the effectiveness of koenimbin on TNF-α-associated apoptosis-inducing ligands in human prostate cancer cells by interfering with the NF-κB-induced antiapoptotic signaling pathway, movement of mitochondrial cytochrome c into the cytosol, sequential activation of caspase-3/7/9, and high and low expression of Bax and Bcl-2 proteins, respectively.
Besides the NF-κB and Bcl-2 family protein members, heat shock proteins 28, 51 are major inhibitors of apoptosis and maintain cell survival through the suppression of mitochondrial cytochrome c release or through the inhibition of apoptosome formation. 7 In the current study, Western blotting results showed a significant decrease in the expression Notes: left to right (A): TnF-α−, TnF-α+, TnF-α+ docetaxel-induced Pc-3 cells (2 µg/ml), TnF-α+ koenimbin-treated Pc-3 (4 µg/ml), TnF-α+ koenimbintreated Pc-3 (8 µg/ml), TnF-α+ koenimbin-treated Pc-3 (16 µg/ml), and β-actin as control (B). nF-κB protein expression in koenimbin-induced Pc-3 cells. representative bar chart indicates that koenimbin suppresses the TnF-α-induced translocation of cytoplasmic nF-κB into the nucleus. The blot densities are expressed as fold change compared to control using imageJ (https://imagej.net) online software (C). Data are mean ± sD (n=3). *P0.05 vs control. Abbreviation: nF-κB, nuclear factor-kappa B. of HSP70 protein in koenimbin-induced PC-3 cells. This result corresponds to the outcomes of a previous report which revealed that the overexpression of HSP70 has the capability to inhibit the apoptotic process. 7, 52 According to CSC concept, subpopulation of CSCs confers chemotherapy resistance. Numerous dietary compounds, comprising koenimbin, 7 curcumin 53,54 sulforaphane, 55 and synthetic compounds including monobenzyltin Schiff base complex, 56, 57 revealed the chemopreventive properties toward CSCs. In this study, the anticancer activity of koenimbin against human PCSCs was examined in vitro to manifest the chemopreventive activity of koenimbin and the implications of the CSC concept. However, there is a limitation for the current study to undertake a clinical trial of koenimbin in prostate cancer patients. Methods including prostasphere formation, CD markers, and Aldefluor enzymatic assay are used for isolation and identification of PCSCs in vitro. Isolation and expansion of prostate stem/progenitor cells 7, 58, 59 using nonadherent prostasphere formation assay rely on the collapse of differentiated cells to survive and proliferate in serum-free suspension compared to stem/progenitor cells. 60 Corroborating with earlier evidences 7, 61 that prostaspheres are formed principally of CSCs, our results demonstrated that koenimbin significantly repressed the formation of prostate stem cell prostaspheres, suggesting that koenimbin has the capability to target PCSCs derived from PC-3 cells in vitro. The important avenue for comparing between prostate stem/progenitor cells and differentiated cancer cells encompasses the employment of cell markers and ALDH enzyme activity. 7 ALDH is significantly expressed in numerous different tumors comprising brain, breast, colon, liver, lung, and pancreatic cancers. 62 ALDH-positive cells from CSCs demonstrated the effective potential for tumor-initiating cells with increased multiplication rate, metastasis, and adhesion capability. In this study, koenimbin revealed not only rupturing of the prostaspheres from ALDH-positive PC-3 cells but also the reduction in the expression of stem cell CD44+/CD133 markers. Consistent with previous studies, our study shows that koenimbin is able to selectively suppress human breast CSCs in mammosphere formation assay and Aldefluor assay, demonstrating the important potential role of koenimbin to target CSCs.
7
Conclusion
Koenimbin has the capability to induce apoptosis in human androgen-independent PC-3 cells in vitro through the intrinsic signaling pathway and suppression of translocation of cytoplasmic NF-κB into the nucleus. In addition, koenimbin has the effective potential to target PCSCs as affirmed by the prostasphere formation assay and Aldefluor assay. Our study outcomes may assist the search for better cancer therapy approaches via the molecular apoptotic mechanisms through which koenimbin exerts its effects on prostate cancer cells and derived PCSCs. These outcomes may result in the evolution of new chemotherapeutic approaches for the treatment of androgen-independent prostate cancer, for which there is no efficient life-prolonging treatment.
